Rosemary Mazanet
Director/Board Member at ONCTERNAL THERAPEUTICS, INC.
Net worth: 758 827 $ as of 2024-03-30
Profile
Rosemary Mazanet founded Apelles Investment Management LP. She holds the position of President of Rosemary Mazanet LLC, President of R Mazanet LLC and Chief Scientific Officer for Columbia Care, Inc. Dr. Mazanet is also on the board of Oncternal Therapeutics, Inc. In her past career Dr. Mazanet occupied the position of Chief Executive Officer of Breakthrough Therapeutics LLC, Senior Director-Clinical Research at Amgen, Inc., Head of Research at Argenis Capital Advisors LLC, Partner at Apelles Investment Management LP, Venture Partner at Colt Ventures Ltd., Chief Medical Officer & Executive Vice President at Galena Biopharma, Inc. and Chief Scientific Officer & General Partner at Oracle Partners LP. Dr. Mazanet received an undergraduate degree from the University of Virginia and a doctorate from Perelman School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-04 | 2,116,159 ( 0.47% ) | 757 585 $ | 2024-03-30 | |
| 2023-06-27 | 138 ( 0.00% ) | 1 242 $ | 2024-03-30 |
Rosemary Mazanet active positions
| Companies | Position | Start |
|---|---|---|
| THE CANNABIST COMPANY HOLDINGS INC. | Director/Board Member | 2023-09-06 |
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 2021-01-26 |
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Director/Board Member | - |
| R Mazanet LLC | President | 2004-04-30 |
| Rosemary Mazanet LLC | President | - |
| University of Pennsylvania Medical Center | Director/Board Member | - |
Former positions of Rosemary Mazanet
| Companies | Position | End |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Chief Tech/Sci/R&D Officer | 2013-11-06 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Director/Board Member | 2013-04-17 |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Director/Board Member | 2013-04-17 |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Rosemary Mazanet
| University of Virginia | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Perelman School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| AKSYS LTD. | Finance |
| THE CANNABIST COMPANY HOLDINGS INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Private companies | 15 |
|---|---|
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Acelerate, Inc.
 Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Diabetes America, Inc.
 Diabetes America, Inc. Medical/Nursing ServicesHealth Services Founded in 2004, Diabetes America has established a reputation in communities across Texas as a comprehensive health center and management program for individuals with diabetes, providing them with a team of physicians, dietitians, and certified diabetes educators all under one roof. Diabetes America's personalized education and lifestyle support provide patients with lifelong guidance for managing their diabetes and gives them the tools and support they need to take charge of their lives. | Health Services |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Amorcyte, Inc.
 Amorcyte, Inc. Miscellaneous Commercial ServicesCommercial Services Amorcyte, Inc. provides cell therapy product development services. It focuses on developing cell therapeutics for cardiovascular disease. The company was founded by Andrew L. Pecora in 2004 and is headquartered in Allendale, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Argenis Capital Advisors LLC
 Argenis Capital Advisors LLC Investment ManagersFinance Argenis Capital Advisors LLC is an independent hedge fund manager headquartered in New York City. Founded in 2006, the firm provides investment advice to high net worth individual and institutional clients. | Finance |
| Oracle Partners LP | |
| Breakthrough Therapeutics LLC | |
Colt Ventures Ltd.
 Colt Ventures Ltd. Investment ManagersFinance Colt Ventures Ltd (Colt Ventures) is a venture capital firm founded in 2003 by Darren Blanton. The firm is headquartered in Dallas, Texas. | Finance |
Apelles Investment Management LP
 Apelles Investment Management LP Investment ManagersFinance Apelles Investment Management LP is a hedge fund manager located in New York Cit | Finance |
| Rosemary Mazanet LLC | |
| R Mazanet LLC | |
Oncolyze, Inc.
Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Rosemary Mazanet
